Preparing your space
Preparing your space
· ScienceDaily Cancer · November 8, 2026
Scientists at UC San Francisco have developed a powerful new cancer therapy that remains inactive until it reaches the brain, where it switches on to attack deadly tumors. The engineered immune cells, called B-SYNC CAR-T cells, completely eliminated diffuse midline glioma (DMG), an aggressive childhood brain cancer that is almost always fatal within a year, in two mouse models.
Originally published by ScienceDaily Cancer. We curate and add context; they did the reporting.
Read the full story at ScienceDaily Cancer ↗